openPR Logo
Press release

Professional Growth of Viral Conjunctivitis - Global Industry Pipeline Review 2017

08-28-2017 11:24 AM CET | Health & Medicine

Press release from: Viral Conjunctivitis

Professional Growth of Viral Conjunctivitis - Global Industry

Albany, New York, August 28, 2017 : Recent research and the current scenario as well as future market potential of "Viral Conjunctivitis - Pipeline Review, H2 2017" globally.

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Viral Conjunctivitis - Pipeline Review, H2 2017, provides an overview of the Viral Conjunctivitis (Ophthalmology) pipeline landscape.

Viral conjunctivitis, or pinkeye, is a common, self-limiting condition that is typically caused by adenovirus. Viral conjunctivitis is highly contagious, usually for 10-12 days from onset as long as the eyes are red. Symptoms include itchy eyes, tearing, redness, discharge and light sensitivity (with corneal involvement). Treatment includes lubricants, vasoconstrictors and antihistamines.

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=1305537

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Viral Conjunctivitis - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Viral Conjunctivitis (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Viral Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Viral Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II and Preclinical stages are 1, 1 and 4 respectively.

Viral Conjunctivitis (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Viral Conjunctivitis (Ophthalmology).
- The pipeline guide reviews pipeline therapeutics for Viral Conjunctivitis (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Viral Conjunctivitis (Ophthalmology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Viral Conjunctivitis (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Viral Conjunctivitis (Ophthalmology)

Make an Enquiry about TOC @ http://www.researchmoz.us/enquiry.php?type=E&repid=1305537

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Viral Conjunctivitis (Ophthalmology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Viral Conjunctivitis (Ophthalmology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Viral Conjunctivitis - Overview
Viral Conjunctivitis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Viral Conjunctivitis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type

Browse Report @ http://www.researchmoz.us/viral-conjunctivitis-pipeline-review-h2-2017-report.html

Viral Conjunctivitis - Companies Involved in Therapeutics Development
Adenovir Pharma AB
NanoViricides Inc
Panoptes Pharma GesmbH
Shire Plc

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Professional Growth of Viral Conjunctivitis - Global Industry Pipeline Review 2017 here

News-ID: 686392 • Views:

More Releases for Ophthalmology

Ophthalmology EHR Software Market Future Outlook 2023-2029, Industry Demand, Tre …
The Ophthalmology EHR Software Market report understands the present and upcoming future economical consequence across types, countries, and products and applications. It gives exact, up-to-date breakdown of markets and businesses. The report uses trustworthy material and breakdown to achieve an extreme understanding of the current aspects influencing the trade. The report also includes information on Ophthalmology EHR Software Market position owned by other industries. Moreover, the different successful supply platforms
Ophthalmology Devices Market: Advancements in Ophthalmology Devices: Improving E …
Allied Market Research recently said Ophthalmology is the branch of medicine that focuses on the diagnosis and treatment of eye disorders. With advancements in technology, ophthalmology devices have become increasingly sophisticated, improving the accuracy of diagnoses and the effectiveness of treatments. Ophthalmology devices deals with the physiology and diseases of eyes. Ophthalmic devices cover wide range of design types such as glasses, contact lenses, implants, surgical instruments and many others. ♦
Ophthalmology Market in Malaysia, Ophthalmology Industry in Malaysia, Covid-19 I …
Lower Ophthalmology Costs in Malaysia: Ophthalmology cost in Malaysia is estimated to be comparatively less i.e. 40% less or even more than the spending made by a patient on an average for the same treatment in the US and European countries such as the UK, France, Germany and others. Low cost of Ophthalmology in Malaysia allows patients from the other countries to save a significant amount of money while benefiting
Malaysia Ophthalmology Market, Malaysia Ophthalmology Industry, Malaysia Ophthal …
The report titled “Malaysia Ophthalmology Market Outlook to 2025- Increase in Ophthalmic Surgeries & Consultations driven by Increasing Ageing Population Proportion and Ophthalmology Technological Advancements" provides a comprehensive analysis of Ophthalmology Services in Malaysia. The report covers various aspects including market size (Total Revenue, Consultations Revenue, Number of Consultations, Surgery Revenue and Number of Surgeries), Market Segmentations by Clinic Specialty (Multi & Single Specialty), by Private and Public Clinics/Hospitals, By
Ophthalmology Market in Thailand, Ophthalmology Industry in Thailand, Covid-19 I …
The COVID-19 virus has been understood to cause eye-related complications including the formation of nodules in the macular region, cranial nerve palsy, retinal vein occlusion and AMD (Age-related Macular Degeneration) Thailand completed the period for completing WHO launched Vision 2020 program. The program had 3 key targets including control of diseases that affect eye health, development of human resources and provision of appropriate technology and infrastructure The King and Queen of
Thailand Ophthalmology Market, Thailand Ophthalmology Industry, Thailand Ophthal …
The report titled “Thailand Ophthalmology Market Outlook to 2025 By Type of Consultation (Eye Strain/Aesthenopia, General Check-Up, Decreased/Reduced Vision, Allergic Reaction, Deformities of Eye/Eyelids), By Type of Surgery (Cataract, Refractive Error, Glaucoma, Retina Related Diseases and Others), By Region (Bangkok, Central, South, North-East and North) and By Type of Hospital (Single-Specialty and Multi-Specialty)”provides a comprehensive analysis on the status quo of the ophthalmic healthcare in Thailand. The report covers various